261 related articles for article (PubMed ID: 20673799)
1. Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions.
van Horssen J; Drexhage JA; Flor T; Gerritsen W; van der Valk P; de Vries HE
Free Radic Biol Med; 2010 Nov; 49(8):1283-9. PubMed ID: 20673799
[TBL] [Abstract][Full Text] [Related]
2. SETD6 is a negative regulator of oxidative stress response.
Chen A; Feldman M; Vershinin Z; Levy D
Biochim Biophys Acta; 2016 Feb; 1859(2):420-7. PubMed ID: 26780326
[TBL] [Abstract][Full Text] [Related]
3. DJ-1 plays an important role in caffeic acid-mediated protection of the gastrointestinal mucosa against ketoprofen-induced oxidative damage.
Cheng YT; Ho CY; Jhang JJ; Lu CC; Yen GC
J Nutr Biochem; 2014 Oct; 25(10):1045-57. PubMed ID: 25037998
[TBL] [Abstract][Full Text] [Related]
4. Nuclear factor erythroid-derived 2-like 2 (Nrf2) and DJ1 are prognostic factors in lung cancer.
Merikallio H; Pääkkö P; Kinnula VL; Harju T; Soini Y
Hum Pathol; 2012 Apr; 43(4):577-84. PubMed ID: 21943684
[TBL] [Abstract][Full Text] [Related]
5. 15-Deoxy-Δ12,14-prostaglandin J₂ modulates manganese-induced activation of the NF-κB, Nrf2, and PI3K pathways in astrocytes.
Lee E; Yin Z; Sidoryk-Węgrzynowicz M; Jiang H; Aschner M
Free Radic Biol Med; 2012 Mar; 52(6):1067-74. PubMed ID: 22245093
[TBL] [Abstract][Full Text] [Related]
6. Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression.
van Horssen J; Schreibelt G; Drexhage J; Hazes T; Dijkstra CD; van der Valk P; de Vries HE
Free Radic Biol Med; 2008 Dec; 45(12):1729-37. PubMed ID: 18930811
[TBL] [Abstract][Full Text] [Related]
7. Astrocyte-derived retinoic acid: a novel regulator of blood-brain barrier function in multiple sclerosis.
Mizee MR; Nijland PG; van der Pol SM; Drexhage JA; van Het Hof B; Mebius R; van der Valk P; van Horssen J; Reijerkerk A; de Vries HE
Acta Neuropathol; 2014 Nov; 128(5):691-703. PubMed ID: 25149081
[TBL] [Abstract][Full Text] [Related]
8. Enhanced number and activity of mitochondria in multiple sclerosis lesions.
Witte ME; Bø L; Rodenburg RJ; Belien JA; Musters R; Hazes T; Wintjes LT; Smeitink JA; Geurts JJ; De Vries HE; van der Valk P; van Horssen J
J Pathol; 2009 Oct; 219(2):193-204. PubMed ID: 19591199
[TBL] [Abstract][Full Text] [Related]
9. A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein.
Calderon TM; Eugenin EA; Lopez L; Kumar SS; Hesselgesser J; Raine CS; Berman JW
J Neuroimmunol; 2006 Aug; 177(1-2):27-39. PubMed ID: 16782208
[TBL] [Abstract][Full Text] [Related]
10. Decline in DJ-1 and decreased nuclear translocation of Nrf2 in Fuchs endothelial corneal dystrophy.
Bitar MS; Liu C; Ziaei A; Chen Y; Schmedt T; Jurkunas UV
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5806-13. PubMed ID: 22836768
[TBL] [Abstract][Full Text] [Related]
11. Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis.
Nijland PG; Witte ME; van het Hof B; van der Pol S; Bauer J; Lassmann H; van der Valk P; de Vries HE; van Horssen J
Acta Neuropathol Commun; 2014 Dec; 2():170. PubMed ID: 25492529
[TBL] [Abstract][Full Text] [Related]
12. Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions.
Hulshof S; Montagne L; De Groot CJ; Van Der Valk P
Glia; 2002 Apr; 38(1):24-35. PubMed ID: 11921201
[TBL] [Abstract][Full Text] [Related]
13. Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis.
van Horssen J; van der Pol S; Nijland P; Amor S; Perron H
Mult Scler Relat Disord; 2016 Jul; 8():11-8. PubMed ID: 27456869
[TBL] [Abstract][Full Text] [Related]
14. Activation of the astrocytic Nrf2/ARE system ameliorates the formation of demyelinating lesions in a multiple sclerosis animal model.
Draheim T; Liessem A; Scheld M; Wilms F; Weißflog M; Denecke B; Kensler TW; Zendedel A; Beyer C; Kipp M; Wruck CJ; Fragoulis A; Clarner T
Glia; 2016 Dec; 64(12):2219-2230. PubMed ID: 27641725
[TBL] [Abstract][Full Text] [Related]
15. Experimental encephalomyelitis induces changes in DJ-1: implications for oxidative stress in multiple sclerosis.
Lev N; Ickowicz D; Barhum Y; Blondheim N; Melamed E; Offen D
Antioxid Redox Signal; 2006; 8(11-12):1987-95. PubMed ID: 17034344
[TBL] [Abstract][Full Text] [Related]
16. Role of nuclear factor erythroid 2-related factor 2 in the oxidative stress-dependent hypertension associated with the depletion of DJ-1.
Cuevas S; Yang Y; Konkalmatt P; Asico LD; Feranil J; Jones J; Villar VA; Armando I; Jose PA
Hypertension; 2015 Jun; 65(6):1251-7. PubMed ID: 25895590
[TBL] [Abstract][Full Text] [Related]
17. Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions.
Nijland PG; Michailidou I; Witte ME; Mizee MR; van der Pol SM; van Het Hof B; Reijerkerk A; Pellerin L; van der Valk P; de Vries HE; van Horssen J
Glia; 2014 Jul; 62(7):1125-41. PubMed ID: 24692237
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology.
Schreibelt G; van Horssen J; van Rossum S; Dijkstra CD; Drukarch B; de Vries HE
Brain Res Rev; 2007 Dec; 56(2):322-30. PubMed ID: 17761296
[TBL] [Abstract][Full Text] [Related]
19. DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway.
Im JY; Lee KW; Woo JM; Junn E; Mouradian MM
Hum Mol Genet; 2012 Jul; 21(13):3013-24. PubMed ID: 22492997
[TBL] [Abstract][Full Text] [Related]
20. Radical changes in multiple sclerosis pathogenesis.
van Horssen J; Witte ME; Schreibelt G; de Vries HE
Biochim Biophys Acta; 2011 Feb; 1812(2):141-50. PubMed ID: 20600869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
